Tadalafil 5 mg

DRUG10 trials

Sponsors

Eli Lilly and Company, Yuyu Pharma, Inc., Fayoum University Hospital, Assiut University, Tri-Service General Hospital

Conditions

Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia (BPH)Chemotherapy Induced Peripheral Neuropathy (CIPN)Erectile DysfunctionErectile Dysfunction Following Radical ProstatectomyErectile DysfunctionsLeft Ventricular Diastolic DysfunctionMetabolic Syndrome

Phase 1

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

CompletedNCT03240939

Yuyu Pharma, Inc.Benign Prostatic Hyperplasia

Start: 2017-03-27End: 2017-10-10Updated: 2017-11-24

Phase 2

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension

CompletedNCT00783094

Eli Lilly and CompanyBenign Prostatic Hyperplasia

Start: 2008-11-30End: 2010-04-30Updated: 2011-03-29

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

CompletedNCT07333976

Tri-Service General HospitalChemotherapy Induced Peripheral Neuropathy (CIPN), Neurotoxicity, Prostate Cancer Metastatic Disease

Start: 2020-01-05End: 2024-08-13Updated: 2026-01-12

Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy

Not yet recruitingNCT07576335

Surgical Outcomes Research Centre (SOuRCe)Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer, Urinary Incontinence Following Surgical Procedure

Start: 2026-05-01End: 2028-11-01Target: 64Updated: 2026-05-08

Phase 3

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia

CompletedNCT00970632

Eli Lilly and CompanyBenign Prostatic Hyperplasia (BPH)

Start: 2009-10-31End: 2011-01-31Updated: 2012-03-12

Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study

Not yet recruitingNCT07177326

Assiut UniversityErectile Dysfunction

Start: 2025-10-01End: 2026-12-01Target: 142Updated: 2025-09-24

Phase 4

Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study

CompletedNCT06947265

Fayoum University HospitalErectile Dysfunctions

Start: 2024-01-14End: 2025-02-01Updated: 2025-04-27

Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study

RecruitingNCT07416968

Mansoura UniversityOveractive Bladder (OAB), Overactive Bladder Syndrome

Start: 2025-09-01End: 2026-12-01Target: 480Updated: 2026-02-18

Association Between Diastolic Dysfunction and Erectile Dysfunction and the Effect of Tadalafil and SGLT2 Inhibitors on Them in Men With Metabolic Syndrome

CompletedNCT07563647

Kafrelsheikh UniversityErectile Dysfunction, Left Ventricular Diastolic Dysfunction, Metabolic Syndrome

Start: 2025-05-05End: 2026-03-17Updated: 2026-05-04

Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled Trial

CompletedNCT07574268

Menoufia UniversityErectile Dysfunction

Start: 2024-06-01End: 2026-03-01Updated: 2026-05-07

Related Papers

Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.

2012-01-20192 citations